RGEN | | REPLIGEN CORP | Cox John | Director | Mar 24, 2020 | Sale | $96.72 | 1,858 | 179,706 | 923 | Mar 26, 2020, 07:31 PM |
RGEN | | REPLIGEN CORP | Cox John | Director | Mar 18, 2020 | Option Exercise | $59.82 | 53,472 | 3,198,638 | 29,517 | Mar 20, 2020, 04:25 PM |
RGEN | | REPLIGEN CORP | Cox John | Director | Mar 04, 2020 | Sale | $53.15 | 20,000 | 1,063,000 | 12,781 | Mar 05, 2020, 05:52 PM |
RGEN | | REPLIGEN CORP | Cox John | Director | Feb 24, 2020 | Sale | $92.81 | 4,455 | 413,455 | 7,136 | Feb 26, 2020, 04:27 PM |
BIVV | | Bioverativ Inc. | Cox John | Chief Executive Officer | Feb 22, 2018 | Option Exercise | $104.30 | 13,973 | 1,457,384 | 190,888 | Feb 26, 2018, 05:11 PM |
BIVV | | Bioverativ Inc. | Cox John | Chief Executive Officer | Feb 23, 2018 | Option Exercise | $104.74 | 5,794 | 606,864 | 185,094 | Feb 26, 2018, 05:11 PM |
BIVV | | Bioverativ Inc. | Cox John | Chief Executive Officer | Feb 14, 2018 | Option Exercise | $103.52 | 10,819 | 1,119,983 | 204,861 | Feb 15, 2018, 05:04 PM |
BIVV | | Bioverativ Inc. | Cox John | Chief Executive Officer | Feb 11, 2018 | Option Exercise | $37.07 | 26,053 | 965,771 | 199,013 | Feb 13, 2018, 05:01 PM |
BIVV | | Bioverativ Inc. | Cox John | Chief Executive Officer | Mar 31, 2017 | Option Exercise | $54.46 | 8,416 | 458,335 | 180,632 | Apr 03, 2017, 04:16 PM |
BIVV | | Bioverativ Inc. | Cox John | Chief Executive Officer | Feb 28, 2017 | Option Exercise | $46.09 | 37,931 | 1,748,144 | 223,575 | Mar 02, 2017, 04:08 PM |
BIIB | | BIOGEN INC. | Cox John | EVP Pharmaceutical Oper & Tech | Feb 23, 2016 | Option Exercise | $258.99 | 382 | 98,934 | 30,516 | Feb 25, 2016, 05:04 PM |
BIIB | | BIOGEN INC. | Cox John | EVP Pharmaceutical Oper & Tech | Feb 12, 2016 | Option Exercise | $247.22 | 1,552 | 383,685 | 30,088 | Feb 17, 2016, 06:01 PM |
BIIB | | BIOGEN INC. | Cox John | EVP Pharmaceutical Oper & Tech | Feb 08, 2016 | Option Exercise | $250.77 | 1,324 | 332,019 | 28,342 | Feb 09, 2016, 04:51 PM |
BIIB | | BIOGEN INC. | Cox John | EVP Pharmaceutical Oper & Tech | Mar 25, 2015 | Option Exercise | $335.37 | 17,076 | 5,726,782 | 37,577 | Mar 26, 2015, 04:31 PM |
BIIB | | BIOGEN IDEC INC. | Cox John | EVP Pharmaceutical Oper & Tech | Feb 12, 2015 | Option Exercise | $392.11 | 1,761 | 690,506 | 32,511 | Feb 17, 2015, 08:40 PM |
BIIB | | BIOGEN IDEC INC. | Cox John | EVP Pharmaceutical Oper & Tech | Feb 09, 2015 | Option Exercise | $396.88 | 2,210 | 877,105 | 30,534 | Feb 10, 2015, 05:07 PM |
BIIB | | BIOGEN IDEC INC. | Cox John | EVP Pharmaceutical Oper & Tech | Feb 08, 2015 | Option Exercise | $402.00 | 1,537 | 617,874 | 28,053 | Feb 10, 2015, 05:07 PM |
BIIB | | BIOGEN IDEC INC. | Cox John | EVP Pharmaceutical Oper & Tech | Feb 23, 2014 | Option Exercise | $347.11 | 1,228 | 426,251 | 25,478 | Feb 25, 2014, 02:17 PM |
BIIB | | BIOGEN IDEC INC. | Cox John | EVP Pharmaceutical Oper & Tech | Feb 12, 2014 | Option Exercise | $323.04 | 1,059 | 342,099 | 24,108 | Feb 14, 2014, 04:34 PM |
BIIB | | BIOGEN IDEC INC. | Cox John | EVP Pharmaceutical Oper & Tech | Feb 08, 2014 | Option Exercise | $315.54 | 1,441 | 454,693 | 20,442 | Feb 11, 2014, 06:07 PM |
BIIB | | BIOGEN IDEC INC. | Cox John | EVP Pharmaceutical Oper & Tech | Feb 09, 2014 | Option Exercise | $315.54 | 2,212 | 697,974 | 22,921 | Feb 11, 2014, 06:07 PM |
BIIB | | BIOGEN IDEC INC. | Cox John | EVP Pharmaceutical Oper & Tech | May 03, 2013 | Option Exercise | $218.85 | 866 | 189,524 | 18,060 | May 07, 2013, 01:33 PM |
BIIB | | BIOGEN IDEC INC. | Cox John | EVP Pharmaceutical Oper & Tech | Feb 23, 2013 | Option Exercise | $164.40 | 1,227 | 201,719 | 18,759 | Feb 26, 2013, 01:26 PM |
BIIB | | BIOGEN IDEC INC. | Cox John | EVP Pharmaceutical Oper & Tech | Feb 09, 2013 | Option Exercise | $164.44 | 1,836 | 301,912 | 17,388 | Feb 12, 2013, 05:10 PM |
BIIB | | BIOGEN IDEC INC. | Cox John | EVP Pharmaceutical Oper & Tech | Feb 08, 2013 | Option Exercise | $164.44 | 1,133 | 186,311 | 14,532 | Feb 12, 2013, 05:10 PM |
BIIB | | BIOGEN IDEC INC. | Cox John | EVP Pharmaceutical Oper & Tech | May 03, 2012 | Option Exercise | $134.26 | 765 | 102,709 | 12,178 | May 04, 2012, 02:03 PM |
BIIB | | BIOGEN IDEC INC. | Cox John | EVP Pharmaceutical Oper & Tech | Feb 23, 2012 | Option Exercise | $116.70 | 1,085 | 126,619 | 14,291 | Feb 27, 2012, 04:19 PM |
BIIB | | BIOGEN IDEC INC. | Cox John | EVP Pharmaceutical Oper & Tech | Feb 24, 2012 | Option Exercise | $116.39 | 1,578 | 183,663 | 13,506 | Feb 27, 2012, 04:19 PM |
BIIB | | BIOGEN IDEC INC. | Cox John | EVP Pharmaceutical Oper & Tech | Feb 09, 2012 | Option Exercise | $117.78 | 1,504 | 177,141 | 12,776 | Feb 13, 2012, 04:28 PM |
BIIB | | BIOGEN IDEC INC. | Cox John | EVP Pharmaceutical Oper & Tech | Nov 01, 2011 | Option Exercise | $93.62 | 4,350 | 407,247 | 11,763 | Nov 03, 2011, 10:52 AM |
BIIB | | BIOGEN IDEC INC. | Cox John | EVP Pharmaceutical Oper & Tech | May 03, 2011 | Option Exercise | $97.99 | 765 | 74,962 | 9,588 | May 04, 2011, 02:51 PM |
BIIB | | BIOGEN IDEC INC. | Cox John | EVP Pharmaceutical Oper & Tech | Apr 21, 2011 | Sale | $86.44 | 8,700 | 751,985 | 14,703 | Apr 25, 2011, 02:02 PM |
BIIB | | BIOGEN IDEC INC. | Cox John | EVP Pharmaceutical Oper & Tech | Apr 13, 2011 | Option Exercise | $68.37 | 72,468 | 4,954,366 | 46,587 | Apr 15, 2011, 11:50 AM |
BIIB | | BIOGEN IDEC INC. | Cox John | EVP Pharmaceutical Oper & Tech | Apr 11, 2011 | Sale | $62.96 | 13,800 | 868,848 | 17,253 | Apr 13, 2011, 10:14 AM |
BIIB | | BIOGEN IDEC INC. | Cox John | EVP Pharmaceutical Oper & Tech | Mar 31, 2011 | Sale | $58.25 | 5,680 | 330,860 | 12,658 | Apr 01, 2011, 03:20 PM |
BIIB | | BIOGEN IDEC INC. | Cox John | EVP Pharmaceutical Oper & Tech | Mar 02, 2011 | Sale | $70.10 | 4,041 | 283,259 | 12,401 | Mar 03, 2011, 03:10 PM |
BIIB | | BIOGEN IDEC INC. | Cox John | EVP Pharmaceutical Oper & Tech | Feb 24, 2011 | Option Exercise | $67.26 | 1,202 | 80,847 | 14,463 | Feb 28, 2011, 03:32 PM |
BIIB | | BIOGEN IDEC INC. | Cox John | EVP Pharmaceutical Oper & Tech | Feb 23, 2011 | Option Exercise | $66.76 | 680 | 45,397 | 15,190 | Feb 25, 2011, 03:56 PM |
BIIB | | BIOGEN IDEC INC. | Cox John | EVP Pharmaceutical Oper & Tech | Feb 17, 2011 | Sale | $67.08 | 1,843 | 123,620 | 13,603 | Feb 18, 2011, 03:06 PM |
BIIB | | BIOGEN IDEC INC. | Cox John | EVP Pharmaceutical Oper & Tech | Feb 12, 2011 | Option Exercise | $65.83 | 910 | 59,905 | 15,446 | Feb 15, 2011, 02:27 PM |
BIIB | | BIOGEN IDEC INC. | Cox John | EVP Pharmaceutical Oper & Tech | Nov 09, 2010 | Sale | $62.87 | 773 | 48,597 | 16,356 | Nov 10, 2010, 02:21 PM |
BIIB | | BIOGEN IDEC INC. | Cox John | EVP Pharmaceutical Oper & Tech | Nov 09, 2010 | Sale | $62.87 | 773 | 48,597 | 16,356 | Nov 10, 2010, 02:21 PM |
BIIB | | BIOGEN IDEC INC. | Cox John | EVP Pharmaceutical Oper & Tech | Nov 01, 2010 | Option Exercise | $62.55 | 360 | 22,518 | 17,894 | Nov 03, 2010, 01:50 PM |
BIIB | | BIOGEN IDEC INC. | Cox John | EVP Pharmaceutical Oper & Tech | Nov 02, 2010 | Sale | $63.04 | 765 | 48,228 | 17,129 | Nov 03, 2010, 01:50 PM |
BIIB | | BIOGEN IDEC INC. | Cox John | EVP Pharmaceutical Oper & Tech | Nov 02, 2010 | Sale | $63.04 | 765 | 48,228 | 17,129 | Nov 03, 2010, 01:50 PM |
BIIB | | BIOGEN IDEC INC. | Cox John | EVP Pharmaceutical Oper & Tech | Nov 01, 2010 | Option Exercise | $62.55 | 360 | 22,518 | 17,894 | Nov 03, 2010, 01:50 PM |
BIIB | | BIOGEN IDEC INC. | Cox John | EVP Pharmaceutical Oper & Tech | Oct 28, 2010 | Sale | $48.49 | 13,800 | 669,093 | 25,154 | Oct 29, 2010, 02:25 PM |
BIIB | | BIOGEN IDEC INC. | Cox John | EVP Pharmaceutical Oper & Tech | Oct 28, 2010 | Sale | $48.49 | 13,800 | 669,093 | 25,154 | Oct 29, 2010, 02:25 PM |